Augsburger J J
Wills Eye Hospital, Department of Ophthalmology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Trans Am Ophthalmol Soc. 1988;86:499-560.
This thesis presents the author's experience with diagnostic intraocular fine needle aspiration biopsy in 18 patients with a suspected metastatic choroidal or ciliary body tumor. The author has reviewed the literature on biopsy of intraocular tumors and has specified what he believes to be valid indications for diagnostic biopsy of posterior uveal tumors. He has evaluated the accuracy, limitations, and complications of diagnostic fine needle aspiration biopsy in this series and others, and he has suggested methods for improving the recovery of sufficient cells for cytologic diagnosis and lessening the risks of tumor cell seeding during the biopsy. The author has concluded that fine needle aspiration biopsy appears to be a relatively safe, generally reliable means of establishing the pathologic diagnosis of a choroidal or ciliary body tumor in highly selected patients suspected of having metastatic cancer. In spite of its apparent safety and reliability, however, the author has cautioned against the routine use of fine needle aspiration biopsy in patients with posterior uveal tumors since its long-term safety has not been established. The author has suggested that diagnostic fine needle aspiration biopsy of posterior uveal tumors be performed only in medical centers where there can be input from and cooperation among ophthalmologists, ophthalmic pathologists, and cytopathologists who are experienced in the diagnosis of intraocular malignancies.
本论文介绍了作者对18例疑似脉络膜或睫状体转移性肿瘤患者进行诊断性眼内细针穿刺活检的经验。作者回顾了眼内肿瘤活检的相关文献,并明确了他认为对后葡萄膜肿瘤进行诊断性活检的有效指征。他评估了本系列及其他研究中诊断性细针穿刺活检的准确性、局限性和并发症,并提出了提高获取足够细胞用于细胞学诊断的回收率以及降低活检过程中肿瘤细胞播散风险的方法。作者得出结论,对于高度怀疑患有转移性癌症的特定患者,细针穿刺活检似乎是一种相对安全、总体可靠的方法,可用于确立脉络膜或睫状体肿瘤的病理诊断。然而,尽管其表面上安全可靠,但作者告诫不要在后葡萄膜肿瘤患者中常规使用细针穿刺活检,因为其长期安全性尚未确立。作者建议,后葡萄膜肿瘤的诊断性细针穿刺活检仅应在有眼科医生、眼科病理学家和在眼内恶性肿瘤诊断方面经验丰富的细胞病理学家参与并合作的医疗中心进行。